Veltassa
Payments companies reported to CMS as associated with Veltassa. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Veltassa, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Veltassa
These are the largest totals companies reported as associated with Veltassa. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Kevin Griffiths | Washington, DC | Internal Medicine | $35,192.57 |
| Gates Colbert | Dallas, TX | Nephrology (Internal Medicine) | $33,576.59 |
| Luis Garcia-Mayol | Coral Gables, FL | Nephrology (Internal Medicine) | $31,069.20 |
| Anjay Rastogi | Los Angeles, CA | Nephrology (Internal Medicine) | $31,040.58 |
| Carlos Bejar | Fort Lauderdale, FL | Nephrology (Internal Medicine) | $26,471.85 |
| Deep Patel | Mechanicsville, VA | Nephrology (Internal Medicine) | $23,280.34 |
| Christopher Gisler | Pittsburgh, PA | Nephrology (Internal Medicine) | $21,053.13 |
| Rodolfo Batarse | Rancho Mirage, CA | Nephrology (Internal Medicine) | $17,445.22 |
| Abdul Abdellatif | Webster, TX | Nephrology (Internal Medicine) | $12,411.62 |
| Lawrence Byrd | Livingston, NJ | Nephrology (Internal Medicine) | $11,808.11 |
Prescribed Veltassa?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.